首页 | 本学科首页   官方微博 | 高级检索  
     检索      

The Antagonistic Effect of Cholecystokinin Octapeptide (CCK-8) on Opioid Effects in Cardiovascular Activities Was Mediated by CCK-B Receptor
作者姓名:梅林  韩济生
作者单位:Department of Physiology,Beijing Medical University,Beijing 100083,PRC,Department of Physiology,Beijing Medical University,Beijing 100083,PRC
基金项目:Project supported by the National Natural Science Foundation of China.
摘    要:Previous studies have shown that CCK-8 has distinct antiopioid effect in the central sites related with pain control and blood pressure control. The aim of this study was to explore the receptor mechanism by which CCK-8 antagonized the depressor effect of u- and k-opioid(?) agonists, and to observe whether CCK-8 could antagonize the depressor effect induced by muscimol, a nonopioid substance. The results showed that (i) The antagonistic effect of CCK-8 on opioid-induced hypotension could be blocked by intrathecal (i.t.) administration of CCK-B antagonist L-365, 260 at nanogram doses, or by CCK-A antagonist devazepide at doses 20—40 times higher than L-365, 260, indicating that it was the CCK-B receptor which mediates the antiopioid effect. (ⅱ) The depressor effect induced by intrathecal muscimol, a GABA agonist, was blocked neither by naloxone nor by CCK-8, supporting the notion that CCK-8 is an endogenous opioid antagonist rather than a universal anti-hypotension agent.


The Antagonistic Effect of Cholecystokinin Octapeptide (CCK-8) on Opioid Effects in Cardiovascular Activities Was Mediated by CCK-B Receptor
MEI Lin HAN Ji-Sheng.The Antagonistic Effect of Cholecystokinin Octapeptide (CCK-8) on Opioid Effects in Cardiovascular Activities Was Mediated by CCK-B Receptor[J].Science in China(Chemistry),1993(7).
Authors:MEI Lin HAN Ji-Sheng
Abstract:
Keywords:cholecystokinin octapeptide  opioid peptides  blood pressure  L-365  260  devazepide  proglumide  muscimol  
本文献已被 CNKI 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号